Prefilled Eylea Syringe: our recent experience
Eye (Lond)
.
2021 Aug;35(8):2083-2085.
doi: 10.1038/s41433-021-01523-z.
Epub 2021 Apr 19.
Authors
Eleni Karatsai
1
,
Shruti Chandra
1
,
Sandro Fasolo
1
,
Sobha Sivaprasad
1
,
Robin Hamilton
2
Affiliations
1
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
2
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK. robin.hamilton1@nhs.net.
PMID:
33875826
PMCID:
PMC8302758
DOI:
10.1038/s41433-021-01523-z
No abstract available
Publication types
Letter
MeSH terms
Humans
Receptors, Vascular Endothelial Growth Factor*
Recombinant Fusion Proteins
Syringes*
Substances
Recombinant Fusion Proteins
aflibercept
Receptors, Vascular Endothelial Growth Factor
Grants and funding
MR/P027881/1/MRC_/Medical Research Council/United Kingdom